MedTrace Logo

Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma

NCT00003801 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-08-20

No results posted yet for this study

Summary

RATIONALE: Cancer treatment may have risks that affect health outcomes later. It is not yet known what health outcomes may be related to previous treatment for rhabdomyosarcoma.

PURPOSE: Study to determine health outcomes in patients who have survived 5 years after receiving treatment for rhabdomyosarcoma on the Intergroup Rhabdomyosarcoma Study Group protocols.

Conditions

  • Long-term Effects Secondary to Cancer Therapy in Children
  • Sarcoma

Interventions

PROCEDURE

management of therapy complications

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • Pediatric Oncology Group

    collaborator OTHER

  • Children's Cancer Group

    collaborator OTHER

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • William M. Crist, MD · University of Missouri-Columbia

  • Michael P. Link, MD · Stanford University

  • R. Beverly Raney, MD · M.D. Anderson Cancer Center

Study Design

Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003801 on ClinicalTrials.gov